All Title Author
Keywords Abstract

PLOS ONE  2013 

Simulated Estimates of Pre-Pregnancy and Gestational Diabetes Mellitus in the US: 1980 to 2008

DOI: 10.1371/journal.pone.0073437

Full-Text   Cite this paper   Add to My Lib

Abstract:

Purpose To simulate national estimates of prepregnancy and gestational diabetes mellitus (GDM) in non-Hispanic white (NHW) and non-Hispanic black (NHB) women. Methods Prepregnancy diabetes and GDM were estimated as a function of age, race/ethnicity, and body mass index (BMI) using South Carolina live singleton births from 2004–2008. Diabetes risk was applied to a simulated population. Age, natality and BMI were assigned to women according to race- and age-specific US Census, Natality and National Health and Nutrition Examination Surveys (NHANES) data, respectively. Results From 1980–2008, estimated GDM prevalence increased from 4.11% to 6.80% [2.68% (95% CI 2.58%–2.78%)] and from 3.96% to 6.43% [2.47% (95% CI 2.39%–2.55%)] in NHW and NHB women, respectively. In NHW women prepregnancy diabetes prevalence increased 0.90% (95% CI 0.85%–0.95%) from 0.95% in 1980 to 1.85% in 2008. In NHB women from 1980 through 2008 estimated prepregnancy diabetes prevalence increased 1.51% (95% CI 1.44%–1.57%), from 1.66% to 3.16%. Conclusions Racial disparities in diabetes prevalence during pregnancy appear to stem from a higher prevalence of prepregnancy diabetes, but not GDM, in NHB than NHW.

References

[1]  Metzger BE, Coustan DR (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21 Suppl 2B161–167.
[2]  Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539–553.
[3]  Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1S5–20.
[4]  Lawrence JM, Contreras R, Chen W, Sacks DA (2008) Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care 31: 899–904.
[5]  Hunt KJ, Schuller KL (2007) The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 34: 173–199, vii.
[6]  Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25: 1862–1868.
[7]  Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373: 1773–1779.
[8]  Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, et al. (2012) Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age/Clinical Perspective. Circulation 125: 1367–1380.
[9]  Shah BR, Retnakaran R, Booth GL (2008) Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus. Diabetes Care 31: 1668–1669.
[10]  Barker DJ (1995) Fetal origins of coronary heart disease. BMJ 311: 171–174.
[11]  Dunne F, Brydon P, Smith K, Gee H (2003) Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990–2002. Diabet Med 20: 734–738.
[12]  Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, et al. (2000) Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49: 2208–2211.
[13]  Freinkel N (1980) Banting Lecture 1980. Of pregnancy and progeny. Diabetes 29: 1023–1035.
[14]  Hunt KJ, Marlow NM, Gebregziabher M, Ellerbe CN, Mauldin J, et al. (2012) Impact of maternal diabetes on birthweight is greater in non-Hispanic blacks than in non-Hispanic whites. Diabetologia 55: 971–980.
[15]  Pettitt DJ, Knowler WC (1998) Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care 21 Suppl 2B138–141.
[16]  Pettitt DJ, Knowler WC, Baird HR, Bennett PH (1980) Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 3: 458–464.
[17]  Pettitt DJ, Knowler WC, Bennett PH, Aleck KA, Baird HR (1987) Obesity in offspring of diabetic Pima Indian women despite normal birth weight. Diabetes Care 10: 76–80.
[18]  Silverman BL, Rizzo T, Green OC, Cho NH, Winter RJ, et al. (1991) Long-term prospective evaluation of offspring of diabetic mothers. Diabetes 40 Suppl 2121–125.
[19]  Mainous A, Baker R, Koopman R, Saxena S, Diaz V, et al. (2007) Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way. Diabetologia 50: 934–940.
[20]  Boyle JP, Honeycutt AA, Narayan KMV, Hoerger TJ, Geiss LS, et al. (2001) Projection of Diabetes Burden Through 2050. Diabetes Care 24: 1936–1940.
[21]  King H, Aubert RE, Herman WH (1998) Global Burden of Diabetes, 1995–2025: Prevelence, numerical estimates, and projections. Diabetes Care 21: 1414–1431.
[22]  National Center for Health Statistics (2012) Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. In: Statistics NCfH, editor. Hyattsville, Maryland. pp. Table 3. Crude birth rates, fertility rates, and birth rates, by age, race, and Hispanic origin of mother: United States, selected years 1950–2008.
[23]  US Census Bureau (1980) 1980 Census of Population and Housing County Population by Age, Sex, Race, and Spanish Origin. pp. Table IV.
[24]  US Census Bureau (1992) 1990 Census of Population: General Population Characteristics. pp. Table 13: Single Years of Age by Sex, Race, and Hispanic Origin: 1990.
[25]  US Census Bureau (2004) Population Projections: U.S. Interim Projections by Age, Sex, Race, and Hispanic Origin: 2000–2050 In: Division P, editor. pp. Detailed Data Files.
[26]  Miller DR, Safford MM, Pogach LM (2004) Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 27 Suppl 2B10–21.
[27]  Engstrom JL, Paterson SA, Doherty A, Trabulsi M, Speer KL (2003) Accuracy of self-reported height and weight in women: an integrative review of the literature. J Midwifery Womens Health 48: 338–345.
[28]  Ezzati M, Martin H, Skjold S, Vander Hoorn S, Murray CJ (2006) Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med 99: 250–257.
[29]  Caro JJ (2005) Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 23: 323–332.
[30]  Caro JJ, Moller J, Getsios D (2010) Discrete event simulation: the preferred technique for health economic evaluations? Value Health 13: 1056–1060.
[31]  Brandle M, Azoulay M, Greiner RA (2011) Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland. Int J Clin Pharmacol Ther 49: 217–230.
[32]  Erhardt W, Bergenheim K, Duprat-Lomon I, McEwan P (2012) Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis. Clin Drug Investig 32: 189–202.
[33]  Pollock RF, Valentine WJ, Pilgaard T, Nishimura H (2011) The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective. J Med Econ 14: 36–46.
[34]  Mission JF, Ohno MS, Cheng YW, Caughey AB (2012) Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 207: 326 e321–329.
[35]  Law AM, Kelton WD (2000) Simulation Modeling and Analysis: McGraw-Hill Higher Education.
[36]  Law AM, Kelton WD (2000) Simulation modeling and analysis. Boston: McGraw-Hill. xxi, 760 p. p.
[37]  Albrecht SS KE, Bansil P, Jamieson DJ, Whiteman MK, Kourtis AP, et al. (2012) Diabetes trends among delivery hospitalizations in the U.S., 1994–2004. Diabetes Care 33: 768–773.
[38]  Getahun D NC, Ananth CV, Chavez MR, Smulian JC (2008) Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 198.
[39]  Lydon-Rochelle MT, Holt VL, Cardenas V, Nelson JC, Easterling TR, et al. (2005) The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol 193: 125–134.
[40]  Brunner Huber LR (2007) Validity of self-reported height and weight in women of reproductive age. Matern Child Health J 11: 137–144.
[41]  Lederman SA, Paxton A (1998) Maternal reporting of prepregnancy weight and birth outcome: consistency and completeness compared with the clinical record. Matern Child Health J 2: 123–126.
[42]  Park S, Sappenfield WM, Bish C, Bensyl DM, Goodman D, et al. (2011) Reliability and validity of birth certificate prepregnancy weight and height among women enrolled in prenatal WIC program: Florida, 2005. Matern Child Health J 15: 851–859.
[43]  Oken E, Taveras EM, Kleinman KP, Rich-Edwards JW, Gillman MW (2007) Gestational weight gain and child adiposity at age 3 years. Am J Obstet Gynecol 196: 322 e321–328.
[44]  Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358: 1991–2002.
[45]  Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF (2003) Lifetime risk for diabetes mellitus in the United States. JAMA 290: 1884–1890.
[46]  O’Sullivan JB, Gellis SS, Dandrow RV, Tenney BO (2003) The potential diabetic and her treatment in pregnancy. Obstet Gynecol 1966;27: 683–9. Obstet Gynecol 102: 7.

Full-Text

comments powered by Disqus